[HTML][HTML] CNS border-associated macrophages in the homeostatic and ischaemic brain

G Gerganova, A Riddell, AA Miller - Pharmacology & Therapeutics, 2022 - Elsevier
CNS border-associated macrophages (BAMs) are a small population of specialised
macrophages localised in the choroid plexus, meningeal and perivascular spaces. Until …

Low-dose aspirin and the risk of stroke and intracerebral bleeding in healthy older people: secondary analysis of a randomized clinical trial

GC Cloud, JD Williamson, C Tran, CB Eaton… - JAMA Network …, 2023 - jamanetwork.com
Importance Low-dose aspirin has been widely used for primary and secondary prevention of
stroke. The balance between potential reduction of ischemic stroke events and increased …

[HTML][HTML] A narrative review of the lesser known medications for treatment of restless legs syndrome and pathogenetic implications for their use

PG Yeh, K Spruyt, LM DelRosso… - Tremor and Other …, 2023 - ncbi.nlm.nih.gov
Background: There are several well-known treatments for Restless Legs Syndrome (RLS),
including dopamine agonists (pramipexole, ropinirole, rotigotine), anticonvulsants …

Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage

R Al-Shahi Salman, SM Greenberg - Stroke, 2023 - Am Heart Assoc
This focused update about antiplatelet agents to reduce the high risk of major adverse
cardiovascular events after stroke due to spontaneous (nontraumatic) intracerebral …

Comparison of Different Laboratory Tests to Identify “Aspirin Resistance” and Risk of Vascular Events among Ischaemic Stroke Patients: A Double-Blind Study

N Venketasubramanian, SJ Agustin, JL Padilla… - Journal of …, 2022 - mdpi.com
“Aspirin resistance”(AR) is associated with increased risk of vascular events. We aimed to
compare different platelet function tests used in identifying AR and assess their implications …

To study the mechanism of panax notoginseng in the treatment of aspirin resistance in the secondary prevention of stroke based on TLR4/MyD88/NF-κB signaling …

H Wang, J Yuan, Y Wang, J Chen - Medicine, 2022 - journals.lww.com
Conclusion: The present study aims to investigate short-term add-on efficacy and
mechanism of Panax notoginseng (Sanqi) for aspirin resistance in secondary stroke …

[HTML][HTML] Cilostazol versus Aspirin or Clopidogrel for Reducing Post-Stroke Aspiration Pneumonia: A Nationwide Retrospective Cohort Study

S Sato, H Yamana, R Kumazawa, H Watanabe… - Cerebrovascular …, 2024 - karger.com
Introduction: The association between the use of cilostazol as a post-stroke antiplatelet
medication and a reduction in post-stroke pneumonia has been suggested. However …

[HTML][HTML] 急性缺血性卒中患者二级预防药物依从性影响因素与干预研究进展

王能鑫, 张蓓, 严琴琴 - Advances in Clinical Medicine, 2024 - hanspub.org
本文介绍了药物依从性的定义和评价方法, 并讨论了导致急性缺血性卒中患者不遵循药物治疗的
具体原因. 最后, 文章提出了一些可以改善患者药物依从性和减少复发的策略 …

Comparative effectiveness of dual antiplatelet therapy versus monotherapy in patients with ischemic stroke

RA Algarni, AA Althagafi, S Alshehri, M Alshibani… - Neurosciences …, 2023 - nsj.org.sa
Objectives: To compare the effectiveness of aspirin-clopidogrel dual antiplatelet therapy
(DAPT) with aspirin or clopidogrel antiplatelet monotherapy (AM) in patients with ischemic …

Antithrombotic Therapy for Heterogeneous Causes of Stroke

AA Kalanuria, M Walker, G Ling - Ischemic Stroke Therapeutics: A …, 2024 - Springer
Ischemic stroke is a leading cause of death and a primary cause of long-term disability.
Patients surviving the initial event are at a high risk of recurrent ischemic events, highlighting …